The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL)
International Journal of Molecular Sciences · 02.10.2024 · 25 (19) · 10626
DOI: 10.3390/ijms251910626 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.10.2024. Verfasst von Qingyue Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Center for Ocean Mega-Science, Chinese Academy of S…. Hauptthemen laut MEDLINE: Protein Kinases, Phylogeny, Evolution, Molecular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science & Technology Innovation Project of Laoshan Laboratory, Science Fund Program for Distinguished Young Scholars of Shandong Province (Overseas), Innovation Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
In mammals, mixed lineage kinase domain-like protein (MLKL) is the executor of necroptosis. MLKL comprises an N-terminal domain (NTD), which alone suffices to trigger necroptosis by forming pores in the plasma membrane, and a C-terminal domain that inhibits the NTD activity. Evolutionarily, MLKL is poorly conserved in animals and not found in Protostomia. Although MLKL orthologs exist in invertebrate Deuterostomia, the biological activity of invertebrate MLKL is unknown. Herein, we examined 34 metazoan phyla and detected MLKL not only in Deuterostomia but also in Protostomia (Rotifera). The Rotifera MLKL exhibited low identities with non-Rotifera MLKL but shared relatively high identities with non-metazoan MLKL. In invertebrates, MLKL formed two phylogenetic clades, one of which was represented by Rotifera. In vertebrates, MLKL expression was tissue-specific and generally rich in immune organs. When expressed in human cells, the MLKL-NTD of Rotifera, Echinodermata, Urochordata, and Cephalochordata induced strong necroptosis. The necroptotic activity of Rotifera MLKL depended on a number of conserved residues. Together these findings provided new insights into the evolution of MLKL in Metazoa and revealed the biological activity of invertebrate MLKL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Center for Ocean Mega-Science, Chinese Academy of Sciences, Qingdao 266404, China.
- Laboratory for Marine Biology and Biotechnology, Qingdao Marine Science and Technology Center, Qingdao 266237, China.
- College of Marine Sciences, University of Chinese Academy of Sciences, Qingdao 266404, China.
Förderung
- Science & Technology Innovation Project of Laoshan Laboratory
- Science Fund Program for Distinguished Young Scholars of Shandong Province (Overseas)
- Innovation Research Group Project of the National Natural Science Foundation of China
- Science & Technology Innovation Project of Laoshan Laboratory
- Oceanographic Data Center, Institute of Oceanology, Chinese Academy of Sciences
Zitieren
APA
Wang, Q., Yuan, Z., Xu, H., Chen, Y., & Sun, L. (2024). The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL). International Journal of Molecular Sciences, 25(19), 10626. https://doi.org/10.3390/ijms251910626
Vancouver
Wang Q, Yuan Z, Xu H, Chen Y, Sun L. The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL). International Journal of Molecular Sciences. 2024;25(19):10626. doi:10.3390/ijms251910626
BibTeX
@article{Wang2024,
author = {Wang, Qingyue and Yuan, Zihao and Xu, Hang and Chen, Yuan and Sun, Li},
title = {The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL)},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {19},
pages = {10626},
doi = {10.3390/ijms251910626}
}
EUVIMED